NHSE RSV Pharmacy Expansion (London Region)

Tender description

NHS London Commercial Hub (acting on behalf of NHS England London Region) conducted a competitive procedure under PSR regulations for the award of the RSV Pharmacy expansion services from a commencement date of September 2025 following conclusion of the standstill period. The contract will continue until 31 March 2027, with an option for the Commissioner to extend until 31 March 2029 at their discretion. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 does not apply to this award. Lot 1: The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 does not apply to this award. NHS London Commercial Hub (acting on behalf of NHS England London Region) conducted a competitive procedure under PSR regulations for the award of the RSV Pharmacy expansion services from a commencement date of September 2025 following conclusion of the standstill period. The contract will continue until 31 March 2027, with an option for the Commissioner to extend until 31 March 2029 at their discretion. Following a competitive procedure, the following sites have been awarded to the corresponding pharmacies: NEL1 - Laville Ltd, Medicos Prime Health, S&A Pharma, Dunedene Ltd NEL2 - Asvacare Ltd, Safedale Ltd, AV (bees) Ltd NEL3 - Safedale Ltd, Laville Ltd, Medicos Prime NEL4 - Laville Ltd, Well Chadwell Heath NEL5 - Mildcare Ltd, Laville Ltd NEL6 - Laville Ltd NEL7 - Asvacare (Subject to confirmation) NWL1 - No bid/ bidder suitable NWL2 - No bid/ bidder suitable NWL3 - No bid/ bidder suitable NWL4 - Hayes End Healthcare Ltd NWL5 - No bid/ bidder suitable NWL6 - No bid/ bidder suitable NWL7 - No bid/ bidder suitable NWL8 - No bid/ bidder suitable NWL9 - No bid/ bidder suitable NWL10 - No bid/ bidder suitable NWL11 - Greenlight Healthcare Ltd NWL12 - Betapharma Ltd NWL13 - Shah Pharmacy Ltd NWL14 - Surreal Medicare Ltd NWL15 - No bid/ bidder suitable NWL16 - Finstead UK Ltd NWL17 - Surreal Medicare Ltd t/a Jade Pharmacy NCL1 - Radiant Medicare t/a Jade Pharmacy NCL2 - No bid/ bidder suitable NCL3 - No bid/ bidder suitable NCL4 - No bid/ bidder suitable NCL5 - Greenlight Healthcare Ltd NCL6 - Well Enfield, Well Enfield NCL7 - Well Enfield NCL8 - Nuvara Medicare NCL9 - No bid/ bidder suitable NCL10 - No bid/ bidder suitable NCL11 - No bid/ bidder suitable NCL12 - No bid/ bidder suitable NCL13 - No bid/ bidder suitable NCL14 - Well Highgate NCL15 - Kanari Ventures Ltd t/a Clan Pharmacy SEL1 - Kingshield Pharmacy Ltd SEL2 - New Park Pharmacy Ltd SEL3 - No bid/ bidder suitable SEL4 - No bid/ bidder suitable SEL5 - Lockyer's Pharmacy SEL6 - Tayzana Ltd SEL7 - UK Apothecary SWL1 - Well Bexley SWL2 - No bid/ bidder suitable SWL3 - Pi-Gen Group (Barkers Pharmacy & Parade Pharmacy) SWL4 - Tayzana Ltd SWL5 - Aksam Ltd SWL6 - Well Roehampton SWL7 - No bid/ bidder suitable SWL8 - Pearl Chemist SWL9 - Pearl Chemist All bids were evaluated against the criteria set by PSR and evaluated scores were moderated. Qualifying (Procurement Specific Questionnaire) also applied with winning bidders selected.